Literature DB >> 1378261

Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions.

G M Anderson, E S Pollak, D Chatterjee, J F Leckman, M A Riddle, D J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1378261     DOI： 10.1001/archpsyc.1992.01820070078016

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  10 in total

1.  The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Authors:  Bekir B Artukoglu; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 2.  Genetic susceptibility and neurotransmitters in Tourette syndrome.

Authors:  Peristera Paschou; Thomas V Fernandez; Frank Sharp; Gary A Heiman; Pieter J Hoekstra
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

3.  Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome.

Authors:  S Cohrs; T Rasch; S Altmeyer; J Kinkelbur; T Kostanecka; A Rothenberger; E Rüther; G Hajak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

4.  Tourette Syndrome: Bridging the Gap between Genetics and Biology.

Authors:  Petra Richer; Thomas V Fernandez
Journal:  Mol Neuropsychiatry       Date:  2015-09-04

Review 5.  Functional Evaluations of Genes Disrupted in Patients with Tourette's Disorder.

Authors:  Nawei Sun; Jay A Tischfield; Robert A King; Gary A Heiman
Journal:  Front Psychiatry       Date:  2016-02-09       Impact factor: 4.157

6.  Fronto-striatal glutamate in children with Tourette's disorder and attention-deficit/hyperactivity disorder.

Authors:  Jilly Naaijen; Natalie J Forde; David J Lythgoe; Sophie E A Akkermans; Thaira J C Openneer; Andrea Dietrich; Marcel P Zwiers; Pieter J Hoekstra; Jan K Buitelaar
Journal:  Neuroimage Clin       Date:  2016-11-16       Impact factor: 4.881

7.  A Chinese Herbal Formulation, Xiao-Er-An-Shen Decoction, Attenuates Tourette Syndrome, Possibly by Reversing Abnormal Changes in Neurotransmitter Levels and Enhancing Antioxidant Status in Mouse Brain.

Authors:  Jihang Chen; Pou Kuan Leong; Hoi Yan Leung; Wing Man Chan; Zhonggui Li; Jingyu Qiu; Kam Ming Ko; Jianping Chen
Journal:  Front Pharmacol       Date:  2019-07-24       Impact factor: 5.810

8.  Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Authors:  K R Müller-Vahl; N Szejko; F Wilke; E Jakubovski; L Geworski; F Bengel; G Berding
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

Review 9.  Candidate Genes and Pathways Associated with Gilles de la Tourette Syndrome-Where Are We?

Authors:  Amanda M Levy; Peristera Paschou; Zeynep Tümer
Journal:  Genes (Basel)       Date:  2021-08-26       Impact factor: 4.096

10.  Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior.

Authors:  Jeremy Veenstra-VanderWeele; Susanne E Ahmari; Muhammad O Chohan; Jared M Kopelman; Hannah Yueh; Zeinab Fazlali; Natasha Greene; Alexander Z Harris; Peter D Balsam; E David Leonardo; Edgar R Kramer
Journal:  Mol Psychiatry       Date:  2022-01-20       Impact factor: 13.437
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.